ENZYME THERAPY FOR TOXIC MOLD SYNDROME AND HOPE FOR PULMONARY FIBROSIS FROM MOLD EXPOSURE

Nattokinase is a naturally occurring enzyme that has fibrinolytic activity and therefore has the ability to break up fibrin clots that may have formed in some small blood vessels.

Formation of fibrin clots is theorized to be one of the causes of the symptoms of toxic mold syndrome.

I have used this supplement in my patients with success in relieving some of the symptoms.

Nattokinase, a fibrinolytic enyzme isolated from Japanese natto, helps to maintain healthy activity of the body's natural clotting and fibrinolytic processes. In an animal study conducted by Biotechnology Research Laboratories and JCR Pharmaceuticals of Kobe, Japan, nattokinase promoted healthy blood flow.


Furthermore, researchers from JCR Pharmaceuticals, Oklahoma State University and Miyazaki Medical College indicated that nattokinase supports healthy clotting function compared to placebo. In 1995, scientists at the Miyazaki Medical College and Kurashiki University in Japan demonstrated the potential for nattokinase to support blood vessel health in human subjects.


This product is contraindicated for individuals with a history of bleeding tendency or with conditions associated with bleeding. Due to potential synergistic effects, concurrent use with anticoagulant and blood pressure medications should be closely supervised by a health professional.


NSK–SD™ is a highly purified fibrinolytic enzyme that has demonstrated encouraging potential for supporting endogenous fibrinolytic activity and promoting healthy blood flow, circulation, and blood vessel function. Pure Encapsulations NSK– SD™ is standardized to contain a minimum of 20,000 FU (fibrinolytic units) per gram.

Nattokinase

Click here to learn more and to order

ENZYME THERAPY FOR PULMONARY FIBROSIS

Idiopathic Pulmonary Fibrosis

 

Definition 

Idiopathic pulmonary fibrosis (IPF) is a chronic disease that causes inflammation (swelling and irritation) and fibrosis (scarring) of tissue in the lungs. The cause of IPF is unknown, and currently there is no FDA approved treatment. It usually occurs in people between ages 50-70.  Pulmonary Fibrosis literally means lung (pulmonary) scarring (fibrosis). The lung scarring occurs in the tissue of the lung called the interstitium, which supports the structures of the lung (air sacs/alveoli). There are an estimated 130-200 related diseases called Interstitial Lung Disease that are similar in characteristics and can result in scarring. Pulmonary Fibrosis causes the lung tissue to thicken and become stiff. Scarring inhibits oxygen from entering the blood stream.

 

 

 

Causes

The word "idiopathic" in the name of this disease means the cause is not known. Researchers think that IPF involves an exaggerated and uncontrolled inflammatory response that produces the fibrous scar tissue. What starts the injury and abnormal healing is not known. Over time, scarring surrounds the thin-walled air sacs in the lungs (alveoli). This makes the tissue thicker and stiffer. As a result, breathing becomes difficult, and the lungs gradually lose their ability to provide oxygen to the rest of the body.

Many people who have been exposed to toxic mold have developed pulmonary fibrosis.

 

Risk Factors

A risk factor is something that increases your chance of getting a disease or condition. Although the cause of IPF is not known, the factors below may increase the risk of getting it:-

Cigarette smoking

- Occupational exposure to metal or wood dust

- Viral infection

- Other family members with IPF

 

Treatment

IPF worsens over time, and there is no known cure. The goal of treatment is to improve symptoms and slow the disease process by reducing inflammation and scarring. It used to be thought that the tissue that is already scarred cannot be returned to normal. Medication was the main form of treatment, although it does not work for some people, and none of these medications have been designed strictly for pulmonary fibrosis. A common combination is prednisone to reduce inflammation along with cytoxan to reduce the body's immune response. Some people may need to receive oxygen to help them breathe. Maintaining a healthy lifestyle in terms of diet, exercise, rest, and not smoking may also help slow the disease. Lung transplantation may be considered for people with advanced IPF who do not respond to other treatment.

 NOW A NEW NATURAL BUT VERY POWERFUL TREATMENT HAS EMERGED

Neprinol AFD , now available without a doctor's prescription, offers excellent hope for those suffering from Pulmonary Fibrosis.  Neprinol is a highly potent systemic enzyme blend.  Enzymes, such as those found in Neprinol AFD, have been found to dissolve scar tissue, and like prescription drugs, work as an anti-inflammatory breaking down scar tissue and restoring health to the area.  Unlike prescription medication, Neprinol has no side-effects, and can be taken for prolonged amounts of time.  If we replace the lost enzymes, we can control and reduce the amount of scar tissue and fibrosis our bodies have. As physicians in the US are now discovering, even old scar tissue can be "eaten away" from surgical wounds, pulmonary fibrosis, and kidney fibrosis even colloid years after their formation.

 

NEPRINOL® is composed of Pharmaceutical-grade ingredients, provided exclusively through licensed healthcare practitioners and supplementation outlet stores. NEPRINOL® is 100% natural and contains no animal derivatives it is available now without a prescription.

Warning:

Neprinol is safe to use with all supplements and all prescription medication except blood-thinners and anticoagulants such as Coumadin, Plavix  and Heparin. Please consult your doctor before taking Neprinol if you are currently taking such a product.

Arthur Andrew Medical - Neprinol, 500 mg, 90 capsules

TO HELP WITH INFLAMMATION AND PAIN -OPC-3


GET CASH BACK FOR SHOPPING ONLINE FOR ALL YOUR SHOPPING NEEDS:

SHOP AT SHOP.COM!